Testing chemotherapy for breast cancer: Timing is everything Journal Article
| Author: | Hudis, C. |
| Article Title: | Testing chemotherapy for breast cancer: Timing is everything |
| Keywords: | cancer chemotherapy; cancer survival; treatment response; clinical trial; bevacizumab; drug efficacy; antineoplastic agents; drug approval; note; capecitabine; gemcitabine; paclitaxel; antineoplastic agent; clinical practice; medical decision making; low drug dose; quality of life; drug administration schedule; editorial; bisphosphonic acid derivative; breast neoplasms; cancer mortality; time; time factors; docetaxel; adjuvant chemotherapy; breast tumor; antiemetic agent; taxoids; taxane derivative; drug administration; toxicity; trastuzumab; navelbine; breast metastasis; growth factor; clinical trials; taxoid |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 24 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-08-20 |
| Start Page: | 5434 |
| End Page: | 5436 |
| Language: | English |
| DOI: | 10.1200/jco.2005.04.015 |
| PUBMED: | 16110004 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 4" - "Export Date: 24 October 2012" - "CODEN: JCOND" - "Source: Scopus" |
